COVID-19: Drugs in Development


The COVID-19 outbreak, which started in December 2019 in Wuhan City, China, was declared a "Public Health Emergency of International Concern" by the WHO on January 30, 2020. The outbreak was characterized as a pandemic on March 11, 2020.

Currently, there are no drugs to treat COVID-19, caused by the novel coronavirus SARS-CoV-2.

Listed below are companies that are in the race to find a treatment or vaccine for the novel coronavirus.

Subscribe to RTT Intelligent Investor for FREE 7-Day Trial with complete access to COVID-19 Drugs in Development Calendar.

Company Name
Current Stage
Next Milestone
Last Updated
ABX464 for COVID-19
Phase 2b/3 study of ABX464 in COVID-19 patients (miR-AGE)
Results from the miR-AGE study expected by year-end
DUR-928 in COVID-19 Patients with Acute Liver or Kidney Injury
Phase 2 study of DUR-928 in hospitalized COVID-19 infected patients with acute liver or kidney injury
Proteostasis Therapeutics, Inc.
PTI-129 as a treatment for COVID-19
PTC Therapeutics Inc.
PTC299 for the treatment for COVID-19
FDA has authorized initiation of a Phase 2/3 trial of PTC299
Lenzilumab in Severe and Critical COVID-19 Patients
Phase III trial of Lenzilumab in severe and critical COVID-19 patients
Citius Pharmaceuticals, Inc.
iMSC therapy to treat ARDS in COVID-19 patients
Submit an IND application for iMSC therapy for patients with Acute Respiratory Distress Syndrome (ARDS) associated with COVID-19

Get Full Access to latest records of COVID-19 Drugs in Development Calendar by subscribing to RTT Intelligent Investor with FREE 7-Day Trial. (No Credit Card Required)

Editors Pick
Polaris Industries Inc. is recalling certain Ranger and General Utility, as well as All-Terrain vehicles citing risks of crash, the U.S. Consumer Product Safety Commission said in a statement. The Medina, Minnesota-based company has called back about 26,730 units of Model Year 2019 - 2020 Ranger XP 1000 & Model Year 2020 General XP 1000 Utility vehicles. Gilead Sciences Inc. (GILD) said Friday that the European Commission has granted conditional marketing authorization for Veklury or remdesivir as a treatment for SARS-CoV-2 infection, the virus that causes COVID-19. FedEx is asking NFL team Washington Redskins to change its name for its racist connotations. The delivery services company, which is a major sponsor for the team, made the suggestion following increasing pressure from its investors amid the ongoing protests against racial injustice and inequality that arose from the killing of African-American George Floyd.